Trial Profile
Evaluation of intralesional administration of rituximab for treatment of orbital lymphoma.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 May 2013
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications B-cell lymphoma; Follicular lymphoma
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 25 Jul 2011 New trial record